➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Express Scripts
McKinsey
McKesson
Merck

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Patent: 4,806,524

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,806,524
Title: Stable erythropoietin preparation and process for formulating the same
Abstract:A stable erythropoietin preparation and a process for formulating the same are disclosed. Erythropoietin is useful in the treatment or diagnosis of anemia, but it is an instable substance. In order to provide a stable erythropoietin preparation, it is formulated with one or more stabilizers selected from the group consisting of polyethylene glycols, proteins, sugars, amino acids, inorganic salts, organic salts and sulfur-containing reducing agents.
Inventor(s): Kawaguchi; Tsutomu (Saitama, JP), Shimoda; Naoto (Saitama, JP)
Assignee: Chugai Seiyaku Kabushiki Kaisha (Tokyo, JP)
Application Number:06/784,256
Patent Claims:see list of patent claims

Details for Patent 4,806,524

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Grifols Usa, Llc PLASBUMIN albumin (human) SOLUTION 101138 1 1994-09-26   Start Trial Chugai Seiyaku Kabushiki Kaisha (Tokyo, JP) 2006-02-21 search
Baxalta Us Inc. FLEXBUMIN albumin human INJECTION, SOLUTION 101452 1 2014-07-31   Start Trial Chugai Seiyaku Kabushiki Kaisha (Tokyo, JP) 2006-02-21 search
Csl Behring Ag ALBURX albumin (human) SOLUTION 102366 1 2009-01-06   Start Trial Chugai Seiyaku Kabushiki Kaisha (Tokyo, JP) 2006-02-21 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.